Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy

Johanna EngströmDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; View further author information

Maria LönnkvistDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; View further author information

Ragnar BefritsDepartment of Medicine, Gastroenterology and Hepatology, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden; View further author information

Tryggve LjungDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; View further author information

Hetzel Diaz-TarteraDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; View further author information

Mikael HolstDepartment of Women’s and Children’s Health, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, SwedenView further author information

Per M. HellströmDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Susana Clemente-Bautista, Iñaki F. Trocóniz, Óscar Segarra-Cantón, Sara Salvador-Marín, Carlos J. Parramón-Teixidó, Marina Álvarez-Beltrán, Luís A. López-Fernández, Helena Colom, Maria J. Cabañas-Poy, Maria Q. Gorgas-Torner & Marta Miarons. (2024) The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model. Pediatric Drugs.
Crossref

Meitong Guo & Xiaoyan Wang. (2023) Pathological mechanism and targeted drugs of ulcerative colitis: A review. Medicine 102:37, pages e35020.
Crossref

Tingpeng Hu, Wei Wang, Fusheng Song, Wenguang Zhang & Jun Yang. (2023) Fecal Calprotectin in Predicting Relapse of Inflammatory Bowel Disease in Children and Adolescents: A Meta-Analysis and Systematic Review. Pediatric Annals 52:9.
Crossref

Fei Peng, Fengyun Chen, Huijun Wen, Jie Bai & Yuping Tian. (2022) Measurement of pre‐treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients. International Journal of Rheumatic Diseases 25:8, pages 844-850.
Crossref

Dan Pu, Zhe Zhang & Baisui Feng. (2022) Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Frontiers in Pharmacology 13.
Crossref

Sheng-long Xia, Quan-jia Min, Xiao-xiao Shao, Dao-po Lin, Guo-long Ma, Hao Wu, Shu-guang Cao & Yi Jiang. (2021) Influence of Vitamin D3 Supplementation on Infliximab Effectiveness in Chinese Patients With Crohn's Disease: A Retrospective Cohort Study. Frontiers in Nutrition 8.
Crossref

José María Giráldez‐Montero, Jaime Gonzalez‐Lopez, Manuel Campos‐Toimil & María Jesús Lamas‐Díaz. (2020) Therapeutic drug monitoring of anti‐tumour necrosis factor‐α agents in inflammatory bowel disease: Limits and improvements. British Journal of Clinical Pharmacology 87:5, pages 2216-2227.
Crossref

Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date